Talazoparib Formulation Bridging in Cancer Patients-Challenges and the Critical Role of Model-Informed Drug Development in Approval Despite Failed Bioequivalence. [PDF]
Wang D +10 more
europepmc +1 more source
Global Proteomic Determination of the Poly-Pharmacological Effects of PARP Inhibitors Following Treatment of High-Grade Serous Ovarian Cancer Cells. [PDF]
Perez JM +3 more
europepmc +1 more source
Proteome-Wide Profiling of Olaparib Interactors Using a Biotinylated Photoaffinity Probe. [PDF]
van der Heijden FLAM +5 more
europepmc +1 more source
Evaluating carboplatin and PARP inhibitor combination efficacy using high-grade serous carcinoma spheroids and organoids. [PDF]
Tomas EJ +3 more
europepmc +1 more source
Identification and Enantiomeric Separation of (+)- and (-)-(E)-3-[5-(2,4-Diaminopyrimidin-5-ylmethyl)-2,3-dimethoxyphenyl]-1-(1-propyl-1H-phthalazin-2-yl)propenone by Supercritical Fluid Chromatography [PDF]
Bunce, Richard A.
core +1 more source
A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma. [PDF]
Siontis BL +11 more
europepmc +1 more source
Identificaiton and Enantiomeric Separation of (+)- and (-)-(E)-3-[5- (2,4Diaminopyrimidin-5-ylmethyl)-2,3-dimethoxyphenyl]-1-(1-propyl-1H-phthalazin-2-yl) propenone by Supercritical Fluid Chromatography [PDF]
Bunce, Richard A.
core +1 more source
Identification and Experimental Validation of Triosephosphate Isomerase 1 as a Functional Biomarker of SHetA2 Sensitivity in Ovarian Cancer. [PDF]
Mortan LF, Isingizwe ZR, Benbrook DM.
europepmc +1 more source
The efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea. [PDF]
Wongchan R +5 more
europepmc +1 more source
E, Oishi, K, Osumi, E, Hayashi
openaire +1 more source

